Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Mar 06, 2023

SELL
$197.11 - $250.07 $41,590 - $52,764
-211 Reduced 19.68%
861 $187,000
Q3 2022

Nov 02, 2022

SELL
$182.44 - $250.54 $37,400 - $51,360
-205 Reduced 16.05%
1,072 $210,000
Q2 2022

Aug 12, 2022

BUY
$204.13 - $302.4 $45,929 - $68,040
225 Added 21.39%
1,277 $273,000
Q1 2022

May 13, 2022

SELL
$255.51 - $362.11 $276,461 - $391,803
-1,082 Reduced 50.7%
1,052 $297,000
Q4 2021

Feb 14, 2022

SELL
$351.38 - $448.68 $130,361 - $166,460
-371 Reduced 14.81%
2,134 $803,000
Q3 2021

Nov 12, 2021

BUY
$372.64 - $458.3 $72,292 - $88,910
194 Added 8.39%
2,505 $1.03 Million
Q2 2021

Aug 10, 2021

BUY
$294.17 - $371.65 $44,713 - $56,490
152 Added 7.04%
2,311 $854,000
Q1 2021

May 11, 2021

BUY
$249.67 - $299.48 $429,682 - $515,405
1,721 Added 392.92%
2,159 $625,000
Q4 2020

Feb 12, 2021

BUY
$222.0 - $252.62 $9,990 - $11,367
45 Added 11.45%
438 $109,000
Q3 2020

Nov 13, 2020

SELL
$175.56 - $226.45 $1,053 - $1,358
-6 Reduced 1.5%
393 $88,000
Q2 2020

Aug 12, 2020

SELL
$118.84 - $189.72 $9,150 - $14,608
-77 Reduced 16.18%
399 $69,000
Q1 2020

May 12, 2020

BUY
$98.9 - $178.34 $8,703 - $15,693
88 Added 22.68%
476 $60,000
Q4 2019

Feb 07, 2020

SELL
$126.05 - $152.76 $68,319 - $82,795
-542 Reduced 58.28%
388 $60,000
Q3 2019

Nov 12, 2019

BUY
$125.07 - $143.67 $71,915 - $82,610
575 Added 161.97%
930 $123,000
Q2 2019

Aug 09, 2019

SELL
$123.4 - $148.55 $23,075 - $27,778
-187 Reduced 34.5%
355 $50,000
Q1 2019

May 10, 2019

BUY
$104.82 - $146.73 $30,292 - $42,404
289 Added 114.23%
542 $79,000
Q1 2018

May 09, 2018

BUY
$98.19 - $115.2 $24,842 - $29,145
253 New
253 $27,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.38B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Rockefeller Capital Management L.P. Portfolio

Follow Rockefeller Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.